Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Gempt

Showing results (221-230 of 256) with videos related to

Pageof 26
Sort By:
JAMA Neurology|August 19, 2024
Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical TrialLars Wessels, Stefan Wolf, Tiziana Adage, et al.
Neuro-Oncology Advances|March 4, 2024
Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth modelMarie-Christin Metz, Ivan Ezhov, Jan C Peeken, et al.
Frontiers in Molecular Biosciences|June 3, 2021
Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma PatientsDominik Lobinger, Jens Gempt, Wolfgang Sievert, et al.
Neuro-Oncology|April 3, 2024
Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patientsFranz L Ricklefs, Kathrin Wollmann, Amanda Salviano-Silva, et al.
Trials|May 29, 2020
Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trialMirjam Renovanz, Melina Hippler, Martin Voss, et al.
Neurosurgical Focus|May 1, 2021
Surgical management of spinal metastases involving the cervicothoracic junction: results of a multicenter, European observational studyVanessa Hubertus, Jens Gempt, Michelle Mariño, et al.
Brain & Spine|November 29, 2023
A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clippingJohannes Kerschbaumer, Christian Franz Freyschlag, Ondra Petr, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Neuro-Oncology Practice|March 9, 2026
Ethical considerations in randomization for neurosurgical oncology trials: A scoping reviewNathan A Shlobin, Mira C Hasner, Philipp Karschnia, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour groupJohnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Pageof 26

Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
JAMA Neurology|August 19, 2024
Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical TrialLars Wessels, Stefan Wolf, Tiziana Adage, et al.
Neuro-Oncology Advances|March 4, 2024
Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth modelMarie-Christin Metz, Ivan Ezhov, Jan C Peeken, et al.
Frontiers in Molecular Biosciences|June 3, 2021
Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma PatientsDominik Lobinger, Jens Gempt, Wolfgang Sievert, et al.
Neuro-Oncology|April 3, 2024
Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patientsFranz L Ricklefs, Kathrin Wollmann, Amanda Salviano-Silva, et al.
Trials|May 29, 2020
Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trialMirjam Renovanz, Melina Hippler, Martin Voss, et al.
Neurosurgical Focus|May 1, 2021
Surgical management of spinal metastases involving the cervicothoracic junction: results of a multicenter, European observational studyVanessa Hubertus, Jens Gempt, Michelle Mariño, et al.
Brain & Spine|November 29, 2023
A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clippingJohannes Kerschbaumer, Christian Franz Freyschlag, Ondra Petr, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Neuro-Oncology Practice|March 9, 2026
Ethical considerations in randomization for neurosurgical oncology trials: A scoping reviewNathan A Shlobin, Mira C Hasner, Philipp Karschnia, et al.
European Journal of Cancer (Oxford, England : 1990)|December 27, 2024
Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour groupJohnny Duerinck, Philipp Karschnia, Marike Broekman, et al.
Pageof 26